Treatment selection was influenced by age, BMI, endocrine metabolic disorders, mental disorders, nervous system disorders, eye/ear complications, diseases of the veins, hypotension, respiratory system and digestive system complications, musculoskeletal and injury at baseline complications, previous XORi, previous UA level, previous albumin, previous normalized protein catabolic rate (nPCR), previous creatinine generation rate (CGR), previous ferritin level, previous serum sodium level and previous dialysis adequacy (KT/V). The gene discussed is ALB; the disease is psychiatric disorder.